Plain-English translation of NCT06448689 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →This study is testing whether a wristband sensor can accurately measure nighttime scratching and sleep problems in people with atopic dermatitis or psoriasis. Many people with these skin conditions experience intense itching that disrupts their sleep and affects their quality of life, but doctors currently have no good way to measure how much scratching happens at night. The researchers are using multiple technologies—including the wrist sensor, video recording, sleep monitoring equipment, and your own reports—to develop and validate this wristband as a tool that could help doctors better understand and treat nighttime scratching.
Nighttime scratching and poor sleep are common complaints in people with atopic dermatitis and psoriasis, but these symptoms are difficult to measure in daily life. By validating a wrist-based sensor, researchers hope to create a practical tool that doctors can use to better track how effective treatments are and to understand the real impact of these conditions on patients' lives.
You likely qualify if…
You likely don't qualify if…
You will wear a special wristband sensor that records your nighttime scratching and sleep patterns. During the study, you'll likely spend at least one night in the research center where researchers will simultaneously use sleep monitoring equipment and video cameras to compare with what the wristband detects. You'll also answer questions about your itching and sleep quality. The study uses these multiple methods together to validate whether the wristband alone can accurately measure scratching behavior without the need for other expensive equipment.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France
Sponsor
ActiGraph L.L.C
Enrollment target
~90 participants
Started
March 2024
Primary completion
March 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
14 Years – 70 Years
Last updated on clinicaltrials.gov in June 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sylvain Zorman, PhD
Université Paris Cité, VIFASOM, ERC 7330, Paris, France;b AP-HP, Hôtel-Dieu, Centre du Sommeil et de la Vigilance, Paris, France
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.